Stock listing

TPEx:6850 Bioptic Inc. (光鼎生技) 股價

Follow Bioptic Inc. into a list and get an email when it puts out news.

Share price · TPEX:6850

$26.00 TWD -0.80 (-3.0%)

Close on Nov 20, 2026

Past year -38.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$26.00 – $26.30 TWDNov 20, 2026
Volume
21,003 sharesNov 20, 2026
Market cap
$860.3M TWDAt the close on Nov 20, 2026 · price × 33.09M shares outstanding
52-week range
$26.00 – $46.00 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$397,936 TWDMedian day 6,000 shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Bioptic Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6850 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$26.00-0.80-3.0%$26.30$26.30$26.0021,003
$26.80-0.40-1.5%$27.50$27.50$26.508,510
$27.20-0.20-0.7%$27.20$27.20$27.203,000
$27.40-1.20-4.2%$27.40$27.40$27.406,000
$28.60+0.45+1.6%$28.60$28.60$28.6020
$28.15+0.50+1.8%$28.50$28.80$28.157,000
$27.65-0.15-0.5%$28.00$28.50$27.4011,000
$27.80+0.30+1.1%$27.50$28.00$27.5010,086
$27.50-0.80-2.8%$28.80$28.80$27.5014,000
$28.30-1.70-5.7%$29.00$29.00$28.0010,500
$30.00+0.95+3.3%$29.05$30.00$29.0022,040
$29.05-0.95-3.2%$29.05$29.35$29.008,020
$30.000.000.0%$30.00$30.00$30.000
$30.000.000.0%$30.00$30.00$30.000
$30.00-0.40-1.3%$30.00$30.00$30.003,000
$30.40+0.40+1.3%$30.00$30.40$30.001,100
$30.000.000.0%$30.00$30.00$30.000
$30.00-0.20-0.7%$30.20$30.20$30.0041,600
$30.200.000.0%$30.20$30.20$30.200
$30.20+0.20+0.7%$29.05$31.55$29.0040,209
$30.000.000.0%$29.80$30.30$28.90223,261
$30.00-0.10-0.3%$29.75$30.30$29.757,243
$30.10-0.90-2.9%$30.70$30.70$30.106,000
$31.00+0.30+1.0%$30.70$31.00$30.705,030
$30.70-0.60-1.9%$31.00$31.00$30.703,001
$31.30+0.10+0.3%$30.70$31.50$30.5027,252
$31.20+0.20+0.6%$31.00$31.20$30.805,003
$31.000.000.0%$31.00$31.30$30.9015,151
$31.00-1.00-3.1%$30.90$31.20$30.906,136
$32.00+0.85+2.7%$32.00$32.50$32.005,525
$31.15+0.15+0.5%$31.00$31.15$31.004,000
$31.000.000.0%$31.60$31.60$31.007,000
$31.00-0.30-1.0%$32.00$32.00$30.904,760
$31.300.000.0%$31.30$31.30$31.300
$31.30-0.20-0.6%$31.00$31.30$31.006,000
$31.500.000.0%$31.50$31.50$31.500
$31.50-0.30-0.9%$31.00$31.70$31.006,000
$31.80+0.10+0.3%$31.70$31.90$31.3034,195
$31.70-0.30-0.9%$31.60$32.35$31.6018,051
$32.00-0.30-0.9%$32.00$32.30$31.6020,396
$32.300.000.0%$32.00$32.30$32.0012,000
$32.30-0.70-2.1%$32.15$32.50$32.1015,002
$33.000.000.0%$32.05$33.30$32.056,100
$33.000.000.0%$33.00$33.00$33.000
$33.00+0.60+1.9%$33.00$33.00$32.4026,000
$32.40-0.90-2.7%$32.80$32.80$32.0510,237
$33.30+0.30+0.9%$33.30$33.30$33.303,000
$33.00+0.90+2.8%$32.10$33.00$32.1016,510
$32.10-1.50-4.5%$32.10$32.10$32.102,000
$33.600.000.0%$33.60$33.60$33.601,000
$33.600.000.0%$33.60$33.60$33.600
$33.600.000.0%$33.60$33.60$33.601,000
$33.60+1.10+3.4%$33.60$33.60$33.601,000
$32.50-0.45-1.4%$32.10$32.80$32.105,126
$32.95-0.20-0.6%$32.85$33.00$31.6552,410
$33.15-0.05-0.2%$33.20$33.20$33.156,000
$33.20-0.30-0.9%$33.20$33.20$33.201,000
$33.50+0.30+0.9%$33.20$33.50$33.155,068
$33.200.000.0%$33.20$33.20$33.201,040
$33.20-0.50-1.5%$34.00$34.00$33.201,115
$33.70+0.55+1.7%$33.45$33.70$33.459,000
$33.15-0.20-0.6%$33.20$33.20$33.0018,000

Splits

3 splits since 2023 · TPEX:6850 · every price before a split is adjusted for it

DayRatioWhat
11-for-10Split
1.1338-for-1Split
11-for-10Split
Ticker
TPEx:6850
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
TPEx
Currency
TWD

Bioptic Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services

Valuation

Price/book 2.0× against a median of 1.3×: 7th lowest of 10 Diagnostics & research services companies shown. balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$743.1M TWD
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
2.0×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.2×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Bioptic Inc. · TPEX:6850US$26.11MUS$22.55Mn/an/an/a2.0×n/a0.2×n/a
MedMira Inc. · TSXV:MIRUS$26.92MUS$27.23Mn/a105×n/an/a−808.2%n/a0.29
BIOQUAL, Inc. · OTC:BIOQUS$26.83MUS$42.28Mn/a1.1×n/a0.8×−11.0%1.0×-0.01
Ikonisys SA · EURONEXT:ALIKOUS$26.75MUS$31.11Mn/a20.4×n/a1.3×−302.8%0.3×n/a
Interpace Biosciences, Inc. · OTC:IDXGUS$26.56MUS$23.63M1.2×0.6×21.0×1.1×58.1%0.0×-0.33
Microbix Biosystems Inc. · TSX:MBXUS$26.27MUS$25.96Mn/a2.4×n/a1.6×−31.7%0.3×0.03
genOway SA · EURONEXT:ALGENUS$25.87MUS$38.95M25.4×1.7×8.7×1.1×4.4%0.7×n/a
Orientbio, Inc. · KRX:002630US$25.03M−US$3.27M14.6×−0.1×−0.8×0.5×8.1%0.0×n/a
Clever Culture Systems Limited · ASX:CC5US$24.62MUS$25.47Mn/a8.3×n/a4.9×−48.4%0.4×n/a
CLEO Diagnostics Ltd · ASX:COVUS$24.57MUS$20.44Mn/an/an/a7.4×n/a0.0×n/a
Genesystem Co., Ltd. · KRX:363250US$24.54MUS$22.35Mn/a29.8×n/a2.8×n/a0.2×n/a
Median of the othersUS$26.07MUS$25.72M14.6×2.4×8.7×1.3×−21.3%0.3×0.01

Financials

Annual, in TWD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue202.7M228.3M231.4M179.3M123.6M92.0M62.1M
Cost of revenue77.4M75.5M78.8M68.9M44.5M41.3M35.4M
Gross profit125.3M152.7M152.6M110.4M79.2M50.6M26.7M
Research and development34.8M40.5M35.5M26.7M20.5M14.8M14.0M
Selling, general and administrative45.3M41.1M31.8M23.8M19.0M21.5M21.1M
Operating income19.2M44.1M65.0M44.2M27.0M3.46M-15.9M
Depreciation and amortization17.1M15.3M10.3M7.09M4.69M3.27M
EBITDA36.2M59.3M75.3M51.2M31.7M-12.6M
Interest expense1.97M1.34M286.0K609.0K1.02M1.24M517.0K
Income before tax27.6M48.4M78.3M49.7M26.4M2.14M-14.9M
Income tax4.67M8.28M15.0M1.06M-194.0K-135.0K239.0K
Net income22.7M37.7M61.3M46.3M25.9M2.19M-14.7M
Earnings per share, basic0.751.252.021.841.300.12-0.83

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents98.1M80.6M207.2M150.0M62.5M33.0M
Short-term investments13.5M13.5M16.0M
Receivables37.3M50.1M31.6M38.1M30.5M19.0M
Inventory155.2M161.1M120.0M77.3M45.0M
Current assets297.8M303.5M372.6M284.9M157.4M49.0M
Goodwill27.6M27.6M
Total assets596.4M613.8M521.4M419.5M290.9M
Accounts payable6.16M29.9M36.6M19.9M8.51M3.85M
Current liabilities47.4M77.5M84.0M42.8M27.7M
Long-term debt75.0M76.9M00
Total debt86.2M93.2M14.3M5.86M86.1M
Total liabilities134.7M170.6M94.1M44.7M109.7M
Shareholders' equity449.7M431.8M418.5M368.1M180.1M
Shares outstanding33.1M30.2M30.2M30.3M25.2M19.9M18.1M17.8M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020
Cash from operations31.1M-12.7M69.5M32.4M14.6M
Capital spending-6.79M-114.1M-6.88M-7.68M-1.03M
Free cash flow24.3M-126.9M62.6M24.7M11.9M
Cash from investing-2.15M-159.0M2.24M-7.72M952.0K
Cash from financing-12.5M45.9M-14.8M62.7M-1.85M
Dividends paid-5.32M-24.2M-11.0M
Change in cash17.5M-126.6M57.2M87.5M13.5M

Open Financials

Cap table

Built by 6ix from Bioptic Inc.’s releases

Common shares
33,089,000
Fully diluted
33,089,000

Fully diluted

LineShares
Common shares33,089,000

Share count over time

CountShares
Nov 22, 202633,089,000

Open Cap table

Shareholders

HolderSharesOf the companyChangeAs of
蔡守冠2.15M6.5%+1,000Oct 31, 2026
盧顯卿1.98M6.0%No changeOct 31, 2026
徐松674K2.0%No changeOct 31, 2026
紀賢良494K1.5%−3,000Oct 31, 2026
許明智475K1.4%No changeOct 31, 2026
翁秀鳳303K0.91%No changeOct 31, 2026
林筱寧245K0.74%−11,000Oct 31, 2026
邱月琴221K0.67%−3,000Oct 31, 2026
藍卿文16,7450.05%No changeOct 31, 2026
張敏夏8,0000.02%No changeOct 31, 2026
All 14 holders
HolderSharesOf the companyChangeAs of
柳雲485<0.01%−100KOct 31, 2026
王永樑00.00%NewOct 31, 2026
蕭淑貞00.00%NewOct 31, 2026
陳永來00.00%NewOct 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Bioptic Inc.